Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Pier Luigi ZinzaniAchiel Van Hoof

Abstract

Radiolabelled immunotherapy is a significant step forward in the treatment of non-Hodgkin's lymphoma (NHL), with preliminary data suggesting long remissions in some patients. 90Y-ibritumomab tiuxetan is the only therapy approved for use after rituximab failure and is currently indicated in the EU for the treatment of adults with rituximab-relapsed or refractory CD20-positive follicular B-cell NHL. However, retrospective analyses confirm better responses when 90Y-ibritumomab tiuxetan is used earlier in the disease course. An expert panel of oncologists, haematologists and nuclear medicine physicians met at an European workshop to discuss proposed therapeutic algorithms for follicular lymphoma and the preliminary medical evidence supporting the incorporation of 90Y-ibritumomab tiuxetan as an early therapeutic option. Phase II data indicate that 90Y-ibritumomab tiuxetan either alone as primary therapy or as consolidation therapy following induction chemotherapy with or without rituximab achieves high response rates in follicular lymphoma, with complete remission rates of 62-80%. Phase III data are warranted, but based on preliminary observations the expert panel recommended incorporation of radiolabelled immunotherapy into nationa...Continue Reading

References

Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen M AnsellThomas E Witzig
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James O ArmitageStewart Kroll
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigPratik S Multani
May 26, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pier Luigi ZinzaniMichele Baccarani
Nov 25, 2004·Hematology·Jane N WinterKoen Van Besien
Feb 4, 2005·The New England Journal of Medicine·Mark S KaminskiRichard L Wahl
Apr 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Hagenbeek, V Lewington
Jun 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wade T SwensonBrian K Link
Nov 3, 2005·Nuclear Medicine Communications·Andreas Otte, Rudi A Dierckx
Jul 15, 2006·Leukemia & Lymphoma·Matthew C CheungUNKNOWN Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care
Sep 26, 2006·Best Practice & Research. Clinical Haematology·Thomas E Witzig
Aug 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Myron S CzuczmanArturo Molina
Feb 28, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P L ZinzaniM Baccarani
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Franck MorschhauserAnton Hagenbeek
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Samuel A JacobsThe Minh Luong
Sep 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael WangAnas Younes

❮ Previous
Next ❯

Citations

Jun 23, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Andrei IagaruMichael L Goris
Feb 12, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E LopciS Fanti
Jun 11, 2011·Best Practice & Research. Clinical Haematology·Tim Illidge, Franck Morschhauser
Aug 17, 2010·Clinical Lymphoma, Myeloma & Leukemia·Pier Luigi ZinzaniMichele Baccarani
May 30, 2014·Targeted Oncology·Evan D ReadTerrence J Piva
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Franck MorschhauserAnton Hagenbeek
Jan 31, 2012·The British Journal of Dermatology·B Lebrun-VignesUNKNOWN French Network of Regional Centers of Pharmacovigilance
Oct 18, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Andrei IagaruMichael L Goris
Oct 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Angelika Bischof DelaloyeAnton Hagenbeek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.